Suchergebnisse
Seiko Epson Corp.
WKN: 471496 / Name: Seiko Epson / Aktie / Büroausstattung / Small Cap /
Siemens Aktie: EPS-Prognose auf 11,50 Euro angehoben
Die Siemens-Aktie fängt sich am Freitag deutlich: Das Papier legt um 1,92 Prozent auf…
Der Beitrag Siemens Aktie: EPS-Prognose auf 11,50 Euro angehoben erschien zuerst auf kapitalmarktexperten.de.
Q
Equinor Aktie: Erste Group senkt EPS-Ziel auf 5,11 Dollar
Die Erwartungen an den norwegischen Energieriesen Equinor werden am Markt derzeit neu justiert. Während…
Der Beitrag Equinor Aktie: Erste Group senkt EPS-Ziel auf 5,11 Dollar erschien zuerst auf kap
Generac Tops Q2 Earnings Estimates, Reaffirms 2026 Revenue Outlook
Generac Holdings Inc. GNRC reported second-quarter 2026 adjusted earnings per share (EPS) of $2.91, which beat the Zacks Consensus Estimate of $1.95. GNRC registered an adjusted EPS of $1.65 in the
BMY Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
Bristol-Myers Squibb Company BMY reported second-quarter 2026 adjusted earnings per share (EPS) of $2.04, which comfortably beat the Zacks Consensus Estimate of $1.59. The reported EPS was up 40%
Should WisdomTree U.S. LargeCap ETF (EPS) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the WisdomTree U.S. LargeCap ETF (EPS), a passively managed exchange traded fund launched on
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised
Merit Medical Systems, Inc. MMSI reported second-quarter 2026 adjusted earnings per share (EPS) of $1.19, up 18% year over year. The figure beat the Zacks Consensus Estimate by 23.9%.
GAAP EPS for
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
DexCom, Inc. DXCM reported second-quarter 2026 adjusted earnings per share (EPS) of 70 cents, which beat the Zacks Consensus Estimate of 61 cents by 14.8%. The company reported adjusted EPS of 48
ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down
AbbVie ABBV reported second-quarter 2026 adjusted EPS of $3.65, which beat the Zacks Consensus Estimate of $3.64. The reported figure also exceeded the company’s guidance of $3.57-$3.61 per share
Altria Group Q2 Earnings Call Highlights
Key Points
- Interested in Altria Group, Inc.? Here are five stocks we like better.
- Altria raised its 2026 adjusted EPS guidance to $5.61–$5.72, after adjusted EPS rose 2.8% year over year to
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus
Krystal Biotech KRYS reported second-quarter 2026 earnings per share (EPS) of $1.79, which surpassed the Zacks Consensus Estimate of $1.70. The company recorded an EPS of $1.29 in the year-ago
Otter Tail Q2 Earnings Call Highlights
Key Points
- Interested in Otter Tail Corporation? Here are five stocks we like better.
- Otter Tail raised its full-year adjusted EPS guidance to $5.68–$6.08, despite second-quarter adjusted EPS
COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised
Cencora, Inc. COR reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $4.48, which beat the Zacks Consensus Estimate of $4.37 by 2.5%. The bottom line increased 12% year over
EQS-News: Scout24 setzt starke Wachstumsdynamik im zweiten Quartal fort: 20 % Umsatzwachstum, anhaltend zweistelliges organisches Wachstum und 18 % Anstieg des bereinigten EPS
Novartis Aktie: Zacks senkt Q3-EPS auf 2,22 Dollar
Die Aktie des Schweizer Pharmakonzerns Novartis rückt zum Ende der Handelswoche verstärkt in das…
Der Beitrag Novartis Aktie: Zacks senkt Q3-EPS auf 2,22 Dollar erschien zuerst auf kapitalmarktexper
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
LivaNova LIVN reported adjusted earnings per share (EPS) of $1.26 for the second quarter of 2026, up 20% year over year. The figure beat the Zacks Consensus Estimate by 16.7%.
GAAP EPS for the
Aflac Misses Q2 EPS Estimates Despite Solid US Sales Growth
Aflac Incorporated AFL reported second-quarter 2026 adjusted earnings per share (EPS) of $1.75, which missed the Zacks Consensus Estimate by 1.1%. The bottom line decreased 1.7% year over year.
Wall Street Raises Visa Outlook After Strong Q3: Buy, Hold or Sell?
Wall Street is growing more bullish on Visa Inc. V after another strong quarterly performance. The Zacks Consensus Estimate for fiscal 2026 EPS has increased five times and fiscal 2027 EPS has